Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sampling Theorem01:15

Sampling Theorem

246
In signal processing, the analysis of continuous-time signals, denoted as x(t), often involves sampling techniques to convert these signals into discrete-time signals. This process is essential for digital representation and manipulation. A critical component in sampling is the train of impulses, characterized by the sampling interval and the sampling frequency. The relationship between these parameters and the original signal's properties dictates the success of the sampling process.
246
Properties of Fourier Transform I01:21

Properties of Fourier Transform I

143
The application of Fourier Transform properties in radio broadcasting is multifaceted, enabling significant advancements in the way signals are transmitted and received. Key areas where these properties are utilized include simultaneous multi-channel transmission, audio clip speed adjustments, live broadcast delays for different time zones, audio frequency adjustments, and signal demodulation.
In radio broadcasting, multiple audio signals often need to be transmitted simultaneously. The Fourier...
143
Parallel Resonance01:23

Parallel Resonance

174
The parallel RLC circuit is an arrangement where the resistor (R), inductor (L), and capacitor (C) are all connected to the same nodes and, as a result, share the same voltage across them. The parallel RLC circuit is analyzed in terms of admittance (Y), which reflects the ease with which current can flow. The admittance is given by:
174
NMR Spectrometers: Overview01:20

NMR Spectrometers: Overview

950
NMR spectrometers consist of a strong magnet, a radiofrequency transmitter, and a detector attached to a computer console for recording spectra of samples containing NMR-active nuclei. In first-generation NMR instruments called continuous-wave spectrometers, the resonance frequencies of the nuclei are determined by frequency-sweep or field-sweep methods. The magnetic field strength is fixed and the rf signal is swept in the former, while the radiofrequency signal is fixed and the magnetic field...
950
Aliasing01:18

Aliasing

100
Accurate signal sampling and reconstruction are crucial in various signal-processing applications. A time-domain signal's spectrum can be revealed using its Fourier transform. When this signal is sampled at a specific frequency, it results in multiple scaled replicas of the original spectrum in the frequency domain. The spacing of these replicas is determined by the sampling frequency.
If the sampling frequency is below the Nyquist rate, these replicas overlap, preventing the original...
100
NMR Spectrometers: Radiofrequency Pulses and Pulse Sequences01:17

NMR Spectrometers: Radiofrequency Pulses and Pulse Sequences

698
A pulse is a short burst of radio waves distributed over a range of frequencies that simultaneously excites all the nuclei in the sample. Upon passing a radio frequency pulse along the x-axis, the nuclei absorb energy corresponding to their Larmor frequencies and achieve resonance. This shifts the net magnetization vector from the z-axis toward the transverse plane. This angle of rotation of the magnetization vector, or the flip angle, is proportional to the duration and intensity of the pulse.
698

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data.

Clinical pharmacology and therapeutics·2026
Same author

Proteomics-Informed Physiologically Based Pharmacokinetic Modeling for Aldehyde Oxidase Substrates in Colorectal Cancer Liver Metastasis.

Molecular pharmaceutics·2026
Same author

Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from k<sub>cat</sub> measurements in matched liver and intestinal samples.

Drug metabolism and disposition: the biological fate of chemicals·2026
Same author

Application of modelling of cell monolayer permeation data to generate input parameters compatible with in vitro-in vivo translation of blood-brain-barrier disposition of drugs.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2026
Same author

Addressing a Common Misconception of Simple Additive and Cumulative Drug Inhibition: Multiple Weak Inhibitors of Common Metabolic Pathway Do Not Pose a Strong Interaction Risk!

Journal of clinical pharmacology·2026

Related Experiment Video

Updated: May 12, 2025

Frequency Mixing Magnetic Detection Scanner for Imaging Magnetic Particles in Planar Samples
07:01

Frequency Mixing Magnetic Detection Scanner for Imaging Magnetic Particles in Planar Samples

Published on: June 9, 2016

9.5K

Simultaneous Estimation of fm and FG Values Directly from Clinical Drug-Drug Interaction Study Data.

Yumi Cleary1,2, Nicolo Milani2, Kayode Ogungbenro1

  • 1Centre for Applied Pharmacokinetic Research, Division of Pharmacy and Optometry, School of Health Sciences, University of Manchester, Manchester, UK.

The AAPS Journal
|April 29, 2025
PubMed
Summary

Two new methods estimate key drug-drug interaction parameters, hepatic metabolic fraction (fm) and intestinal availability (FG), using substrate concentration changes. These approaches aid in predicting drug interactions and informing clinical study design for safer medication use.

Keywords:
drug-drug interaction (DDI)model-informed drug development (MIDD)physiologically-based pharmacokinetic (PBPK) modelling

More Related Videos

Simultaneous fMRI and Electrophysiology in the Rodent Brain
08:22

Simultaneous fMRI and Electrophysiology in the Rodent Brain

Published on: August 19, 2010

13.3K
Simultaneous Data Collection of fMRI and fNIRS Measurements Using a Whole-Head Optode Array and Short-Distance Channels
08:19

Simultaneous Data Collection of fMRI and fNIRS Measurements Using a Whole-Head Optode Array and Short-Distance Channels

Published on: October 20, 2023

945

Related Experiment Videos

Last Updated: May 12, 2025

Frequency Mixing Magnetic Detection Scanner for Imaging Magnetic Particles in Planar Samples
07:01

Frequency Mixing Magnetic Detection Scanner for Imaging Magnetic Particles in Planar Samples

Published on: June 9, 2016

9.5K
Simultaneous fMRI and Electrophysiology in the Rodent Brain
08:22

Simultaneous fMRI and Electrophysiology in the Rodent Brain

Published on: August 19, 2010

13.3K
Simultaneous Data Collection of fMRI and fNIRS Measurements Using a Whole-Head Optode Array and Short-Distance Channels
08:19

Simultaneous Data Collection of fMRI and fNIRS Measurements Using a Whole-Head Optode Array and Short-Distance Channels

Published on: October 20, 2023

945

Area of Science:

  • Pharmacokinetics and Drug Metabolism
  • Computational Biology and Drug Development
  • Clinical Pharmacology

Background:

  • Physiologically-based pharmacokinetic (PBPK) modeling is crucial for drug-drug interaction (DDI) assessment in drug development.
  • Accurate estimation of hepatic metabolic fraction (fm) and intestinal availability (FG) is vital for PBPK models, often relying on clinical data.
  • Current methods for parameter estimation can be data-intensive and may not capture complex interactions.

Purpose of the Study:

  • To propose and evaluate two novel methods for simultaneous estimation of fm and FG.
  • To assess the utility of these methods using extensive virtual and actual CYP3A substrate data.
  • To provide guidance for clinical DDI study design to improve drug labeling for concomitant medications.

Main Methods:

  • The two-dimensional DDI (2D-DDI) method directly estimates fm and FG from area-under-curve (AUCR) and maximum concentration (CmaxR) ratios.
  • The population PBPK method utilizes full substrate concentration-time data with or without an inhibitor.
  • Both methods were validated using over 50,000 virtual and six actual CYP3A substrates.

Main Results:

  • The 2D-DDI method demonstrated speed and reliability without requiring prior PBPK model development.
  • The population PBPK method effectively estimated population parameters and inter-individual variabilities in fm and FG.
  • Both methods showed increased uncertainty for high hepatic extraction substrates, consistent with other approaches.

Conclusions:

  • The proposed 2D-DDI and population PBPK methods offer efficient and robust ways to estimate critical DDI parameters.
  • These methodologies are applicable beyond CYP3A substrates and can inform clinical DDI study design for better drug labeling.
  • The findings support improved risk assessment and prediction of drug interactions, potentially reducing the need for extensive clinical trials.